Mitochondria in health, disease, and aging

JS Harrington, SW Ryter, M Plataki… - Physiological …, 2023 - journals.physiology.org
Mitochondria are well known as organelles responsible for the maintenance of cellular
bioenergetics through the production of ATP. Although oxidative phosphorylation may be …

Role of mitochondrial quality surveillance in myocardial infarction: from bench to bedside

H Zhou, J Ren, S Toan, D Mui - Ageing Research Reviews, 2021 - Elsevier
Myocardial infarction (MI) is the irreversible death of cardiomyocyte secondary to prolonged
lack of oxygen or fresh blood supply. Historically considered as merely cardiomyocyte …

Reactive oxygen species and mitochondrial dynamics: the yin and yang of mitochondrial dysfunction and cancer progression

J Ježek, KF Cooper, R Strich - Antioxidants, 2018 - mdpi.com
Mitochondria are organelles with a highly dynamic ultrastructure maintained by a delicate
equilibrium between its fission and fusion rates. Understanding the factors influencing this …

[HTML][HTML] Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia–reperfusion injury

J Wang, H Zhou - Acta Pharmaceutica Sinica B, 2020 - Elsevier
Mitochondrial damage is a critical contributor to cardiac ischemia/reperfusion (I/R) injury.
Mitochondrial quality control (MQC) mechanisms, a series of adaptive responses that …

The putative Drp1 inhibitor mdivi-1 is a reversible mitochondrial complex I inhibitor that modulates reactive oxygen species

EA Bordt, P Clerc, BA Roelofs, AJ Saladino, L Tretter… - Developmental cell, 2017 - cell.com
Mitochondrial fission mediated by the GTPase dynamin-related protein 1 (Drp1) is an
attractive drug target in numerous maladies that range from heart disease to …

Discovering protein drug targets using knowledge graph embeddings

SK Mohamed, V Nováček, A Nounu - Bioinformatics, 2020 - academic.oup.com
Motivation Computational approaches for predicting drug–target interactions (DTIs) can
provide valuable insights into the drug mechanism of action. DTI predictions can help to …

Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease

JS Bhatti, S Kaur, J Mishra, H Dibbanti, A Singh… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disease that manifests its pathology
through synaptic damage, mitochondrial abnormalities, microRNA deregulation, hormonal …

Mesenchymal stem cells sense mitochondria released from damaged cells as danger signals to activate their rescue properties

M Mahrouf-Yorgov, L Augeul, CC Da Silva… - Cell Death & …, 2017 - nature.com
Mesenchymal stem cells (MSCs) protect tissues against cell death induced by
ischemia/reperfusion insults. This therapeutic effect seems to be controlled by physiological …

Mitochondrial dynamics in neuronal injury, development and plasticity

KH Flippo, S Strack - Journal of cell science, 2017 - journals.biologists.com
Mitochondria fulfill numerous cellular functions including ATP production, Ca2+ buffering,
neurotransmitter synthesis and degradation, ROS production and sequestration, apoptosis …

[HTML][HTML] Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer

M Yu, ND Nguyen, Y Huang, D Lin, TN Fujimoto… - Jci Insight, 2019 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) requires mitochondrial oxidative
phosphorylation (OXPHOS) to fuel its growth; however, broadly inhibiting this pathway might …